Legislators and the Medicare Part D industry are evaluating the impact of possible reforms to the Medicare Part D program. How would Medicare Part D spending be affected if the catastrophic phase included a drug discount program with no beneficiary cost sharing or reduced federal reinsurance?

This report was commissioned by Aetna.